BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17313458)

  • 1. A structure-based, quantitative structure-activity relationship approach for predicting HLA-A*0201-restricted cytotoxic T lymphocyte epitopes.
    Zhou P; Tian F; Li Z
    Chem Biol Drug Des; 2007 Jan; 69(1):56-67. PubMed ID: 17313458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
    Tian F; Yang L; Lv F; Yang Q; Zhou P
    Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the binding affinity of epitope-peptides with HLA-A*0201 by encoding atom-pair non-covalent interaction information between receptor and ligands.
    Hu L; Ai Z; Liu P; Xiong Q; Min M; Lan C; Wang J; Fan L; Chen D
    Chem Biol Drug Des; 2010 Jun; 75(6):597-606. PubMed ID: 20565476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes.
    Goulder PJ; Reid SW; Price DA; O'Callaghan CA; McMichael AJ; Phillips RE; Jones EY
    Eur J Immunol; 1997 Jun; 27(6):1515-21. PubMed ID: 9209505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.
    Liu J; Wu P; Gao F; Qi J; Kawana-Tachikawa A; Xie J; Vavricka CJ; Iwamoto A; Li T; Gao GF
    J Virol; 2010 Nov; 84(22):11849-57. PubMed ID: 20844028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of affinity of HLA-A*0201 restricted CTL epitope based on the SCORE function.
    Zhi-Hua L; Huai-Liang W; Bo Z; Yuan-Qiang W; Yong L; Yu-Zhang W
    Protein Pept Lett; 2009; 16(5):561-9. PubMed ID: 19442236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study.
    Doytchinova IA; Flower DR
    Proteins; 2002 Aug; 48(3):505-18. PubMed ID: 12112675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
    Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
    Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A*0201-restricted cytotoxic T-cell epitopes in three PE/PPE family proteins of Mycobacterium tuberculosis.
    Chaitra MG; Shaila MS; Chandra NR; Nayak R
    Scand J Immunol; 2008 Apr; 67(4):411-7. PubMed ID: 18248530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in cytotoxic T-lymphocyte responses to peptides derived from tyrosinase-related protein-2.
    Myers CE; Dionne SO; Shakalya K; Mahadevan D; Smith MH; Lake DF
    Hum Immunol; 2008 Jan; 69(1):24-31. PubMed ID: 18295672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS.
    Kawashima Y; Satoh M; Oka S; Shirasaka T; Takiguchi M
    Biochem Biophys Res Commun; 2008 Feb; 366(3):612-6. PubMed ID: 18035044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587.
    Xing Q; Pang XW; Peng JR; Yin YH; Li Y; Yu X; Zhou SP; Zhang Y; Chen WF
    Biochem Biophys Res Commun; 2008 Jul; 372(2):331-5. PubMed ID: 18498761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitope.
    Li Z; Oka Y; Tsuboi A; Fujiki F; Harada Y; Nakajima H; Masuda T; Fukuda Y; Kawakatsu M; Morimoto S; Katagiri T; Tatsumi N; Hosen N; Shirakata T; Nishida S; Kawakami Y; Udaka K; Kawase I; Oji Y; Sugiyama H
    Microbiol Immunol; 2008 Nov; 52(11):551-8. PubMed ID: 19090835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients.
    Jin M; Komohara Y; Shichijo S; Harada M; Yamanaka R; Miyamoto S; Nikawa J; Itoh K; Yamada A
    Oncol Rep; 2008 May; 19(5):1277-83. PubMed ID: 18425388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the peptide-T cell receptor interaction by the comparative molecular similarity indices analysis-soft independent modeling of class analogy technique.
    Doytchinova IA; Flower DR
    J Med Chem; 2006 Apr; 49(7):2193-9. PubMed ID: 16570915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the groove: the fine detail of antigen presentation to cytotoxic T lymphocytes.
    Moots RJ
    Clin Sci (Lond); 1993 Jun; 84(6):585-91. PubMed ID: 7687528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
    Adair SJ; Carr TM; Fink MJ; Slingluff CL; Hogan KT
    J Immunother; 2008 Jan; 31(1):7-17. PubMed ID: 18157007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes.
    Fujiki F; Oka Y; Tsuboi A; Kawakami M; Kawakatsu M; Nakajima H; Elisseeva OA; Harada Y; Ito K; Li Z; Tatsumi N; Sakaguchi N; Fujioka T; Masuda T; Yasukawa M; Udaka K; Kawase I; Oji Y; Sugiyama H
    J Immunother; 2007 Apr; 30(3):282-93. PubMed ID: 17414319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.